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The enterovirus 2B/2C cleavage site differs from the common cleavage site motif AxxQ I G by the occurrence 
of either polar residues at the P I ' position or large aliphatic residues at the P4 position. To study (i) the 
putative contribution of these aberrant residues to the stability of precursor protein 2BC, (ii) the determinants 
of cleavage site specificity and efficiency of 3Cprw, and (iii) the importance of efficient cleavage at this site for 
viral replication, a mutational analysis of the coxsackie B3 virus (CBV3) 2B/2C cleavage site (AxxQ j  N) was 
performed. Neither replacement of the P I ' asparagine with a serine or a glycine nor replacement of the P4 
alanine with a valine significantly affected 2B/2C cleavage efficiency, RNA replication, or virus growth. The 
introduction of a P4 asparagine, as can be found at the CBV3 3C/3D cleavage site, caused a severe reduction 
in 2B/2C cleavage and abolished virus growth. These data support the idea that a P4 asparagine is an 
unfavorable residue that contributes to a slow turnover of precursor protein 3CD but argue that it is unlikely 
tha t the aberrant 2B/2C cleavage site motifs serve to regulate 2B/2C processing efficiency and protein 2BC 
stability. The viability of a double mutant containing a P4 asparagine and a P I ' glycine demonstrated that a 
P I ' residue can compensate for the adverse effects of an unfavorable P4 residue. Poliovirus (or poliovirus-like) 
2B/2C cleavage site motifs were correctly processed by CBV 3CprQ, albeit with a reduced efficiency, and yielded 
viable viruses. Analysis of in vivo protein synthesis showed that mutant viruses containing poorly processed 
2B/2C cleavage sites were unable to completely shut off cellular protein synthesis. The failure to inhibit host 
translation coincided with a reduced ability to modify membrane permeability, as measured by the sensitivity 
to the unperm eant translation inhibitor hygromycin B. These data suggest that a critical level of protein 2B or 
2C, or both, may be required to alter membrane permeability and, possibly as a consequence, to shut off host 
cell translation.
Enteroviruses contain a positive-strand RNA genome of 7.5 
kb in length which encodes a single polyprotein. This polypro­
tein is processed by three virus-encoded proteinases, 2Apro, 
3Cpro, and 3CDprcl (Fig. 1A), into the structural PI capsid 
proteins and the rionstructural P2 and P3 proteins that are 
involved in viral RNA (vRNA) replication (reviewed in refer­
ence 50). Proteinase 2Apro cleaves between the PI and P2 
regions cotranslationally (45). The capsid proteins are pro­
cessed in trans by proteinase 3CDpro (26, 51). Processing of the 
nonstructural proteins by proteinase 3Cpro yields both the final 
cleavage products (2A, 2B, 2C, 3A, 3B, 3C, and 3D) and 
relatively stable processing intermediates (2BC, 3AB, and 
3CD) (22). These precursor proteins have functions in vRNA 
replication that are distinct from those of their cleavage prod­
ucts. Protein 3AB is the membrane-bound precursor that de­
livers VPg (3B) to the membranous replication complex (42- 
44). Furthermore, protein 3AB stimulates 3Dpo1 activity and 
the autocatalytic processing of 3CDpro to 3Cp,° and 3Dpo1 (30, 
34, 37). Protein 3CD not only is a proteinase but also is in­
volved in the formation of a ribonucleoprotern complex at the 
5' end of the RNA, which is required for the initiation of viral 
positive-strand RNA synthesis (2, 3, 23). Protein 2BC has been 
proposed to play a role in the induction of the membrane
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vesicles at which viral positive-strand RNA synthesis occurs 
(7). Bienz et al. showed that in poliovirus (PV)-infected cells in 
which polyprotein processing was partially inhibited, the for­
mation of these vesicles always coincided with the production 
of protein 2BC (8). Consistent with this finding, Barco and 
Carrasco demonstrated that the expression of PV protein 2BC, 
but not that of protein 2B or 2C, either individually or in 
combination, induced the formation of membrane vesicles in 
yeast cells (5). The finding that protein 2C alone can induce 
vesicles in human cells (1,14) may have been hampered by the 
use of vaccinia viruses, which modify vesicular traffic them­
selves.
The production and stability of proteins 2BC, 3AB, and 3CD 
require a finely tuned regulation of the temporal processing at 
different cleavage sites in the polyprotein. Proteolysis may be 
regulated by the occurrence of less favorable recognition se­
quences. In PVs, all 3Cpro-mediated cleavages occur between 
glutamine-glycine (Q-G) dipeptide pairs. Additional determi­
nants in substrate recognition, however, have been proposed 
because the PV polyprotein contains four Q-G amino acid 
pairs that are not cleaved and cleavage sites other than Q-G, as 
identified in other enteroviruses (15, 27, 32), were also cleav- 
able by PV protein 3Cpro (17). The amino acid at the P4 
position (i.e., the fourth residue proximal to the Q-G cleavage 
site), which is in most cases an alanine, seems to be a major 
determinant of the efficiency of cleavage. Data that support the 
role of the P4 amino acid in substrate recognition have been 
obtained by mutagenesis of infectious PV cDNA clones (9). 
The importance of the P4 amino acid for the stability of prc-
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FIG. 1, (A) Schematic structure of the 7.5-kb single-stranded RNA genome of CBV3 containing protein VPg at 5' end of the nontranslated region (NTR) and a 
polyadenylate tract at the end of the 3* nontranslated region. The polyprotein-encoding region is shown boxed. The proteinase that is responsible for cleavage at a 
particular cleavage site (indicated by an arrow) is shown below Lhe polyprotein. (B) Alignment of amino acid sequences that occur at the P4-P3-P2-P1/P1' of the 2A/2B, 
2B/2C, 2C/3A, 3A/3B, 3B/3C, and 3C/3D cleavage sites of enteroviruses for which complete sequences of the P2 and P3 regions are known. The enteroviruses are 
divided into a CBV-like subgroup and a PV-like subgroup. Enteroviruses with distinct amino acid sequences are shown apart. Only sequence motifs that differ from 
the most frequently occurring motif AxxQ/G are shown. Abberant amino acids are in boldface, Abbreviations; ECHO, cchovirus; CAV, coxsackic A virus; SVDV, swine 
vesicular disease virus; PV1(S) and PVI(M), PV type I strains Sabin and Mahoney, respectively; PV2(S) and (L), PV type 2 strains Sabin and Lansing, respectively; 
PV3(S) and PV3(L), PV type 3 strains Sabin and Leon, respectively; EV7U, enterovirus Lype 70; BEV1, bovine enterovirus type 1.
cursor protein 3CDpro has been demonstrated by Pallai et al. 
(36), who found that a synthetic peptide containing the au­
thentic PV 3C/3D cleavage site (TxxQ j  G) was resistant to 
hydrolysis by 3Cpro, whereas a peptide containing a substitu­
tion of the threonine by an alanine was efficiently cleaved. 
Other determinants that may affect substrate processing are 
the recognition of secondary or tertiaiy structures and the 
accessibility to a potential cleavage site. Analysis of structural 
data suggests that cleavage sites must be correctly displayed at 
the surface in a flexible turn configuration at the end of an 
a-helix or (3-sheet to be recognized efficiently (4, 35, 36). Pro­
cessing at the 3A/3B cleavage site seems to be determined by 
structural rather than sequence-specific determinants. Lama et 
al. found that only membrane-associated protein 3AB, not 
solubilized 3AB, could be cleaved by 3Cprt\  indicating that 
either the recognition or exposure of the 3A/3B cleavage site, 
which lies in close proximity to the membrane-binding domain 
of protein 3A, is dependent on a hydrophobic environment
(30).
Alignment of the 3Cpro cleavage sites of the enterovirus 
nonstructural proteins (Fig, IB) shows that nearly all entero­
viruses contain the sequence AxxQ 1 G (P4-P3-P2-P1-P1V) at 
their 2A/2B, 2C/3A, 3A/3B, and 3B/3C junctions. The 3C/3D 
cleavage sites differ from this sequence by the occurrence of 
unfavorable residues at the P4 position, which seem to be 
involved in the stability of protein 3CDpro (see above). It is 
remarkable that also all 2B/2C cleavage site motifs are aber­
rant from the sequence AxxQ |  G. Coxsackie B virus (CBV)- 
like viruses contain polar asparagine or serine residues at the
P I7 position rather than a neutral glycine residue. PV-like 
viruses, on the other hand, contain at the P4 position either a 
valine or an isoleucine, residues which are heavily branched at 
the [3-carbon, rather than an alanine, which has only a small 
methyl group as its side chain. The only virus that contains the 
sequence AxxQ I  G at its 2B/2C junction, PV type 2 strain 
Sabin, differs from all other enteroviruses by the occurrence of 
a negatively rather than a positively charged residue at its P2 
position. The occurrence of aberrant sequence motifs at the 
2B/2C cleavage site of all enteroviruses may indicate a regula­
tory role in the kinetics of 2B/2C processing and, thereby, in 
the stability of protein 2BC. To test this possibility and to gain 
more insight in the determinants of the 2B/2C cleavage site 
specificity and processing efficiency, eight mutant coxsackie B3 
virus (CBV3) cDNAs were constructed and the effects of the 
mutations on in vitro poly protein processing were analyzed. To 
understand the importance of efficient cleavage at this site for 
viral replication, the effects of the mutations on virus viability 
and growth, RNA replication, and in vivo protein synthesis 
were assayed.
MATERIALS AND METHODS
Cells and viruses. Virus propagations and vRNA transfections were per­
formed with Buffalo green monkey (BGM) cells. Plaque assays were performed 
with Vero cells. The cells were grown in minimal essential medium (MEM) 
supplemented with 10% fetal calf scrum. After infection, cells were fed with 
MEM containing 3% scrum. After transfection, MEM containing 10% serum 
was added to the cells. Viruses were titrated in 96-well plates with BGM cell 
monolayers as described previously (46). Virus titers were calculated by the
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method of Reed and Muench anti expressed in 50% tissue culture infective dose 
(TCID5n) values (40).
Site-directed mutagenesis. Oligonucleotide-directed site-specific mutagenesis 
was performed with subgenomic phagemid pALTCB3/2080-4947 (46), using the 
Altered Sites in vitro mutagenesis system ^Promega) according to the manufac­
turer’s recommendations. The nucleotide sequences of the synthetic oligonucle­
otides (Isogen Bioscience, Maarssen, The Netherlands) arc 5'-CTFAAGCCAG 
CTATTGCCTTGGCGTTCAGCCAT-3' (mutation 2B/2C-1,G),5'-CTTAAGC 
CAGCTATTTGGTTGGCGTTCAGCCAT-3' (2B/2C-1'P), 5'-CTTAAGCCA 
GCTA TrCGA TTG G CG TTCA GCCAT-3' (2B/2C-1'S), S'-ATTGTTTTGGCG 
TTCGACCATAGGGATTCCGTA-3' (2B/2C-4V), 5 '-ATrGTTTTGGCGCTC 
ATTCATAGGGATTC C G T A -3’ (2B/2C-4N), 5'-CTTAAGCCAGCTATTGCC 
TTGG CGCTCATTCATAGGGATTCCGTA-3' (2B/2C-4N;1'G), 5'-CTTAAG 
CCAG CTATTGCCTTGGCGTTCG ACCATAGGGATTCCGTA-3' (2B/2C- 
4V;1'G), and 5'-CTTAAGCCAATTGCCTTGGCGGATCACCATAGGGAT 
GATTCCGTAATA-37 (2B/2C-4 V;3r; 1'G). Each of these oligonucleotides creat­
ed a novel endonuclease restriction site. Clones carrying the desired mutation 
were identified by restriction enzyme analysis. The nucleotide sequence around 
the 2B/2C junction of these clones was verified by dideoxy-chain termination 
sequencing of plasmid DNA, using primer 5 CCATTCAATGAATTTCTG-3' 
(nucleotides 4117 to 4134). From the mutant clones, the Spel (position 3837)- 
to-B.ysHII (position 4238) fragmenL was cloned in plasmids pCB3/T7, which 
contains a full-length cDNA of CBV3 Nancy behind a T7 RNA polymerase 
promoter (28), and pCB3/T7-LUC, a pCB3/T7-derived construct that contains 
the luciferase gene in place of the capsid coding region (46).
In vitro translation reactions. iSWI-linearized plasmid DNA (0.5 jxg) was 
transcribed and translated in a single reaction, using T7 TNT rabbit reticulocyte 
lysate (Promega) supplemented with HeLa cell initiation factors (kindly pro­
vided by J. Flanegan, University of Florida) and T ran3sS-label (a mixture of 
[3:)Sj methionine and [35S]cysteine; ICN). Labeled proteins were analyzed by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as de­
scribed previously (47).
Transfection of cells with RNA transcripts. Eighty percent confluent BGM cell 
monolayers were transfected with 5 |Jig of full-length copy RNA transcripts, 
generated with T7 RNA polymerase from S«/I-linearizcd cDNA templates, using 
the DEAE-dexlran method as described previously (46). After transfection, the 
cells were grown al either 33 or 36°C. When virus growth was observed, the 
cultures were incubated until cytopathie effect was complete. Otherwise, the 
cultures were subjected to three cycles of freezing and thawing, and 200 |xl was 
passaged to fresh BGM monolayers, which were incubated for another 3 (3 3 ^ )  
or 5 (36°C) days.
Sequence analysis of 2B/2C junction of mutant viruses. vRNA extraction, 
cDNA synthesis, and amplification by PCR using forward primer 5'-GCAATG 
GAACAGGGAGTGAAGGACTATGTGGA-3' (nucleotides 3733 to 3765) and 
reverse primer 5 '-TTGGGATGGCGCGCTCTGCTC-3' (nucleotidcs 4231 to 
4251) were performed as described previously (46). T he  resulting PCR products 
were purified from  low-melling-point agarose, and the nucleotide sequence 
around the 2B/2C junction was determined as described above.
Plaque assays and single-cycle yield analysis. Plaque assays were carried out 
with confluent monolayers of Vcro cells on 10-cm2 dishes in six-well plates as 
described previously (46). To determine the virus yield in a single replicative 
cycle, 100% confluent BGM cell monolayers (5 X 106 cells) were infected with 
virus at an M OI of 1 TCID 5() per cell and grown at either 33, 36, or 39°C. At 8 h 
postinfection, viruses were released by three cycles of freezing and thawing and 
the virus titer was determined.
Analysis of positive-strand RNA synthesis. BGM cell monolayers were trans­
fected with 0.5 (xg of T7 RNA polymerase generated full-length copy RNA 
transcripts of the mutant pCB3/T7'LUC plasmids as described above. At i, 4, 6,
8, and 10 h posttransfection, the cells were lysed and the lucifcrase production 
was measured as described previously (46).
Analysis of viral protein synthesis in vivo. BGM cell monolayers were infected 
with virus at an MOI of 25 for 30 min at room temperature. After infection, cells 
were supplied with new medium and incubated at 36°C. At several times postin- 
fection, protein synthesis was monitored by labeling with 10 |xCi of Tran3SS-label 
in methionine- and serum-free MEM (Gibco). After 30 min, the medium was 
discarded, the cells were lysed in cold lysis buffer, and labeled proteins were 
analyzed by SDS -PAGE as described previously (46).
In experiments in which the permeability of cells to hygromycin B was assayed, 
the same procedure was followed except that cells were incubated in methionine- 
and serum-free MEM, in the presence or absence of 500 p-g of hygromycin B 
(Sigma) per ml. for 15 min prior to the addition of 10 |xCi of Tran35S-label to the 
medium.
To determine the [35S]methionine incorporation, sample lanes were cut from 
the gel and measured in a liquid scintillation counter following SDS-PAGE and 
autoradiography.
RESULTS
Construction and description of CBV3 2B/2C cleavage site 
mutants. Substitution mutations at the 2B/2C cleavage site 
were generated by oligonucleotide-directed mutagenesis and
introduced in infectious CBV3 cDNA clone pCB3/T7 and sub­
genomic replicon pCB3/T7-LUC. The mutants fall into three 
categories. Within the first group are four mutants that were 
constructed to examine the importance of the aberrant PI' or 
P4 residues that occur at the enterovirus 2B/2C cleavage site 
(Fig. IB). For this, the PI' asparagine was replaced with a 
glycine (mutation 2B/2C-1'G), a proline (2B/2C-.1T), or a 
serine (2B/2C-1'S) or the P4 alanine was replaced with a valine 
(2B/2C-4V). The second group consists of two mutants that 
were constructed to examine the effect on 2B/2C cleavage 
efficiency of a P4 asparagine, as can be found at the 3C/3D 
cleavage site of CBV-like viruses. The P4 asparagine was in­
troduced either alone (2B/2C-4N) or, in order to create a site 
that resembles the 3C/3D cleavage site, together with a PI' 
glycinc (2B/2C-4N;1'G). The third group consists of two mu­
tants that were engineered to examine the cross-species sub­
strate specificity of CBV3 3Cpro. In one mutant, a valine was 
introduced at the P4 position and a glycine was introduced at 
the P r  position to create a motif with P4, PI, and PI' residues 
that occur at the 2B/2C junction of most PV-likc viruses (2B/ 
2C-4V;1'G). The other mutant contained an additional re­
placement of the P3 glutamic acid with a isolcucine (2B/2C- 
4V;3I;1'G) to create a P4 to PI' sequence that is identical to 
that found at a PV 2B/2C junction (PV type 3).
In vitro polyprotein processing of 2B/2C cleavage site mu­
tants. The effect of the mutations on the 3Cpro-mediated pro­
cessing at the 2B/2C cleavage site was studied by in vitro 
translation of copy RNA transcripts of the mutant pCB3/T7 
plasmids. Figure 2A shows the protein patterns generated after
3 h. This figure shows that some of the mutations affected the 
efficiency of 2B/2C processing, but not the 2B/2C cleavage site 
specificity, as shown by a correct migration of protein 2C. 
Remarkably, no accumulation of protein 2BC or any other 
potential precursor protein was observed. None of the muta­
tions affected any of the other proteolytic processing events in 
the viral polyprotein, as shown by the normal production of 
other viral proteins, including protein 2A (Fig. 2C), to levels 
similar to those produced by wild-type RNA. Protein 2B (11 
kDa) could not be visualized because it migrated in the heavily 
overloaded globin spot.
To determine the relative efficiency of 2B/2C cleavage, au­
toradiograms from three independent translation experiments 
were analyzed by densitometric scanning and the ratio of pro­
tein 2C/3CD was calculated (to correct for variations in total 
protein yield). The amount of protein 2C produced by RNA 
transcripts carrying mutations 2B/2C-TG and 2B/2C-1.'S was 
similar to that produced by wild-type pCB3/T7 RNA. Mutation 
2B/2C-1'P completely abolished 2B/2C cleavage, Even after 
prolonged exposure of the gels, no protein 2C could be de­
tected. Mutation 2B/2C-4V slightly impaired 2B/2C cleavage, 
and approximately 85% of the wild-type protein 2C amount 
was produced. The introduction of asparagine residues at the 
P4 position (single mutation 2B/2C-4N and double mutation 
2B/2C-4N;1'G) reduced 2B/2C cleavage efficiency to about 
10% of the wild-type level. Mutations 2B/2G4V;TG and 2B/ 
2C-4V;3I;1'G reduced the cleavage efficiency to about 25% of 
that of the wild type.
Effects of 2B/2C cleavage site mutations on RNA replication.
To study the effects of the mutations on positive-strand RNA 
replication, BGM cells were transfected with copy RNA tran­
scripts of wild-type and mutant pCB3/T7-LUC constructs, and 
the luciferase activity was measured at several times posttrans­
fection. Figure 3 shows that none of the mutations interfered 
with the initial increase in luciferase activity (between '1 and
4 h) that reflects translation of the input RNA (46). However, 
some mutations interfered with the second increase in lucif-
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FIG. 3. Effects of 2B/2C cleavage site mutations on RNA replication. RNA transcripts were synthesized from both mutant and wild-type luciferase rcplicin 
pCB3/T7-LUC. BGM cells were transfected with both mutant and wild-type RNA transcripts (0.5 |xg), and the luciferase activity was determined at the indicated timt 
points posttransfcction as described in Materials and Methods,
fection, reflecting the reduced growth rate of this virus. Re­
markably, cellular protein synthesis was reduced but not corn- 
pletely shut off. This feature was also observed with minute-
plaque viruses vCB3-2B/2C-4S, vCB3-2B/2C-4N;l'G, and 
vCB3-2B/2C-4V;l'G, which produced viral proteins in a large 
background of cellular proteins. Even at 10 h postinfection, no 
complete inhibition of cellular translation was observed (data 
not shown). In ceils infected with minute-plaque virus vCB3- 
2B/2C-4V;3I;1'G, virtually no shut off of host cell translation 
occurred. For a comparison of the protein patterns, lysates of 
cells infected with the different mutant viruses were concur­
rently electrophoresed on a single gel (Fig. 4B).
Ability of mutant viruses to increase plasma membrane 
permeability. PV-infected cells show an enhanced permeability 
to monovalent cations and other low-molecular-weight com­
pounds, including the nonpermeant translation inhibitor hy- 
gromycin B, from the third hour postinfection (6, 12). It has 
been suggested that this membrane modification and the re­
sulting alterations in ionic milieu may be involved in the shutoff 
of host cell protein synthesis (12).
To examine whether the failure of the CBV3 mutants to shut 
off cellular translation, correlated with a decreased ability to 
modify membrane permeability, the sensitivity of translation to 
hygromyein B was assayed. Cells were infected with wild-type
virus, vCB3-2B/2C-4V;l'G, or vCB3-2B/2C-4V;3I;l'G and
pulse-lateled in the presence or absence of hygromyein B at 2,
4, 6, and 8 h postinfection. In wild-type virus-infected cells, 
hygrorrn cin B reduced translation about 70% at both 4 and 6 h 
postinfc ction, time points at which cellular translation was 
indeed shut off and when only viral proteins were synthesized 
(Fig. 5 In contrast, hygromyein B had little effect on transla­
tion in cells infected with the mutant viruses. No inhibition of 
translation was observed at 4 and 6 h postinfection, when 
protein synthesis was suppressed to about 40% (vCB3-2B/2C- 
4V;1'G) and 55% (vCB3-2B/2C-4V;3I;l'G) of the level ob­
served at 2 h postinfection. At 8 h postinfection, when trans­
lation was suppressed to about 20% (vCB3-2B/2C4V;rG) 
and 40% (vCB3-2B/2C-4V;3I;l'G), some inhibition of transla­
tion (about 40%) by hygromyein B was observed in cells in-
fectecl with vCB3-2B/2C-4V;l'G but not in cells infected with 
vCB3-2B/2C-4V;3I;l'G.
DISCUSSION
Enterovirus protein 2BC is a proteolytic processing interme­
diate that exerts a specific function in vRNA replication (5,8). 
Protein 2BC is a poor substrate for 3Cpro and is only veiy 
slowly processed into proteins 2B and 2C in vitro (20, 21, 34). 
The stability and function of this protein require a subtle reg­
ulation of processing efficiency at the 2B/2C cleavage site. One 
mechanism to regulate the kinetics of proteolysis is the occur­
rence of unfavorable residues at the scissile bond or positions
TABLE 1. Effects of mutations on 2B/2C cleavage efficiency,
plaque size, and singlc-eycle virus yield
Mutation 2B/2Cjunction"
2B/2C
cleavage''
Plaque
size*
Single-cycle 
virus yield'7
Log(o
TCI D5()/ml
% of wt 
yield
None (wt) AerQ/N H— I—h wt 8.9
2B/2C-1'G AerQ/G wt 9.0
2B/2C-1T AerQ/P Nonviablc
2B/2C-1'S AerQ/S + +  + wt 8.8
2B/2C-4V VerQ/N il« | >■ * | * Small 8.1 15.8
2B/2C-4N NerQ/N ± Nonviablc
2B/2C-4S (revenant) SerQ/N M inute 7.2 2.0
2B/2C-4N;1'G NcrQ/G Minute 7.1 1.7
2B/2C-4V; I 'G Ver Q/G + Minute 7.2 2.0
2B/2C4V;3I;1 'G VirQ/G + Minute 6.4 0.3
“ Amino acids at the P4-P3-P2-P1/P1' positions, respectively. Mutated amino 
acids are in boldface.
h Relative efficiency of cleavage at the 2B/2C junction based on the densito- 
metric analysis of the cell-free cleavage assay shown in Fig. 2,
£ Relative plaque size at 96 h postinfection of confluent Vero cell monolayers, 
wt, wild type.
il Confluent BGM cell monolayers were infected with virus at an MOl of 1 
TCID5(, per ceil and grown at 36°C. At 8 h postinfection, viruses were released 
by freezing and thawing and the virus titer was determined bv endpoint titration.
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may be induced by an interaction with a specific target (e.g., 
membrane or another protein). The observation of Molla et al. 
that the addition of protein 3AB significantly enhanced prote­
olysis of PV protein 2BC by 3Cpro in vitro lends support to such 
a hypothesis (34).
The introduction ot a PV proline (2B/2C-VP) completely 
abolished 2B/2C cleavage. The nonviability of this mutation 
may be due to an adverse effect on the function of protein 2BC 
in vRNA replication. However, it seems more likely that effi­
cient vRNA replication requires the production of either pro­
tein 2B or protein 2C or both. The activities that have been 
ascribed to protein 2B, i.e., inhibition of protein secretion and 
pcrmeabilization of the plasma membrane (16), and protein 
2Cy which is endowed with nucleoside triphosphatase and 
RNA binding activities (31, 41), however, can also be fulfilled 
by protein 2BC (16, 41). The requirement for either mature 
protein 2B or 2C suggests that one of these proteins, or both, 
exerts a yet unidentified function in vRNA replication that 
cannot be fulfilled by protein 2BC. Alternatively, protein 2BC 
may be not be able to exert these activities when engaged with 
other viral proteins.
In the second group of mutants, the effect of P4 asparagine 
on 2B/2C cleavage and viral replication was examined. This 
polar residue has been identified at the P4 position of the 
3C/3D cleavage site of CBV-like viruses. Introduction of this 
residue (2B/2C-4N) reduced the efficiency of 2B/2C cleavage 
to about 10% of that of the wild type. This finding provides 
experimental evidence for a role of this polar residue in deter­
mining a slow turnover rate of protein 3CD, analogous with the 
role of the unfavorable polar threonine occurring at the P4 
position of the PV 3C/3D cleavage site (36). The nonviability 
of this mutation argues that critical levels of protein 2B or 2C, 
or both, are required for efficient virus growth. Alternatively, 
mutation 2B/2C-4N may abolish a function of protein 2B in 
vRNA replication. The mutation did not completely abolish 
vRNA synthesis, as shown by the isolation of a revertant virus 
carrying a P4 serine. The viability of this reversion mutation is 
most probably due to the increase in 2B/2C cleavage efficiency 
(to about 25% of that of the wild type) and, as a consequence, 
the production of increased levels of proteins 2B and 2C. 
These data fit well with the crystal structure of 3Cpro of human 
rhinovirus 14, a picornavirus closely related to enteroviruses
(31). It was found that the S4 substrate pocket of this protein­
ase is small and hydrophobic and that it best accommodates 
small and hydrophobic amino acids. Any change in the P4 
position from a small alipathic to a polar residue results in 
strong energetic constraints. Our data suggest that these con­
straints are more severe with a polar residue containing a large 
side chain (asparagine) than with a small polar residue 
(serine). Impaired processing efficiency was also observed in 
PV genomes that contained a serine, threonine, or glutamic 
acid residue at the P4 position of the cleavage site between two 
genetically engineered VPg coding units (11).
In contrast to nonviable mutation 2B/2C-4N, simultaneous 
introduction of a P4 asparagine and a PV glycine (2B/2C-4N; 
l'G ) yielded viable viruses. That a PV residue (i.e., the first 
amino acid of protein 2C) can intramolecularly compensate for 
a nonviable mutation at the P4 position (i.e., amino acid 96 of 
protein 2B) makes it unlikely that the nonviability of mutation 
2B/2C-4N was due to an impaired function of protein 2B in 
vRNA replication. It seems unlikely that the rescuing effect of 
the PV glycine is due to an effect on the function of protein 2C 
in vRNA replication, because viruses carrying a PV asparagine 
(wild type) or a P I ' glycine (2B/2C-VG) replicated equally 
well. Two alternative explanations must be considered. First, 
the P4, PI, and PV residues may play a synergistic role in
determining the cleavage site conformation, and the compen­
sating effect of the PV glycine may be due to a more efficient 
2B/2C cleavage. All enterovirus 2B/2C cleavage sites contain 
small amino acids at either the P4 position, the P V position, or 
both. Cleavage sites carrying mutation 2B/2C-4N contain as­
paragine residues at both the P4 and PV positions. The simul­
taneous occurrence of such large P4 and PV residues may 
interfere with the cleavage site conformation and, as a conse­
quence, the recognition of the substrate or its accessibility to 
the active center of 3Cprt\  However, no profound differences in 
processing efficiency at sites carrying mutations 2B/2C-4N and 
2B/2C-4N;VG were observed. Densitometric scanning of au­
toradiograms, however, may not be sensitive enough to detect 
minor quantitative differences. It therefore cannot be excluded 
that the additional introduction of a PV glycine causes a subtle 
enhancement of 2B/2C cleavage, leading to levels of proteins 
2B and 2C that are sufficient to enable virus growth. Another 
possibility is that mutation 2B/2C-4N disrupts the structure 
and, as a consequence, the function of precursor protein 2BC 
in vRNA replication, and that the compensating effect of a PI' 
glycine is due to stabilization of the protein conformation.
The third group consisted of two mutants that were engi­
neered to examine the ability of CBV3 3Cpm to process PV (or 
PV-like) 2B/2C cleavage sites. Cleavage sites carrying P4, PI, 
and PV residues that occur at the 2B/2C cleavage site of most 
PV-like viruses (2B/2C-4V;1'G) or P4 to P V residues that are 
identical as those found at the 2B/2C cleavage site of PV type
3 (2B/2C-4V;3I;1'G) were correctly processed by CBV3 3Cpro, 
albeit with a reduced efficiency (about 25% of that of the wild 
type). These findings are consistent with the impaired cleavage 
of P2 proteins observed with a chimeric PV polyprotein con­
taining CBV3 protein 3Cprt) (15). The cross-species substrate 
specificity of CBV3 3Cpro confirms the existence of both con­
formational and sequence-specific cleavage determinants. The 
finding that double mutation 2B/2C-4V;1'G reduccd cleavage 
efficiency to a much greater extent than each of the single 
mutations did supports the proposed synergistic action of the 
P4, PI, and PV residues in determining the cleavage site con­
formation (see above). The P3 residue seems to be of less 
importance for the cleavage site conformation, as mutations
2B/2C-4V; VG and 2B/2C-4V;3I;1'G had similar effects on 
cleavage efficiency, The finding that mutation 2B/2C-4V;3l; 
VG reduced virus growth to a greater degree than mutations 
that caused reductions in cleavage efficiency that were similar 
(2B/2C-4V;VG and 2B/2C-4S) or even more severe (2B/2C- 
4N;1 'G) suggests that the P3 glutamic acid is a determinant of 
the structure and function of protein 2B, or 2BC, in vRNA 
synthesis rather than of 2B/2C cleavage efficiency. This view is 
consistent with structural data for human rhinovirus 14 3Cpro, 
which suggested that the side chain groups of residues at the P5 
and P3 positions are pointing away from the active center of 
3Cpro (31).
Analysis of the viral protein synthesis in vivo showed that 
none of the minute-plaque viruses containing poorly processed 
2B/2C cleavage sites was capable to completely inhibit cellular 
protein synthesis. A reduced but significant amount of cellular 
proteins was continuously synthesized in cells infected with 
viruses carrying mutations 2B/2C-4S, 2B/2C-4N; VG, and 2B/ 
2C-4V;VG, while viruses carrying mutation 2B/2C-4V;3I;1'G 
caused virtually no shutoff of host cell translation. The simul­
taneous synthesis of viral and cellular proteins late in infection 
is remarkable and has, to our knowledge, not been demon­
strated previously. It is unlikely that this situation is due to the 
reduced growth rate of these viruses, since it was not observed 
with other CBV3 mutants that exhibited a similar or an even 
more severe decrease in growth (47, 48). The mechanism by
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which enteroviruses shut off host cell translation is still de­
bated. According to the traditional view, the shut off of cellular 
translation relies only on the protein 2Ap,'°-mediated cleavage 
of the 220-kDa component (p220) of eucaryotic initiation fac­
tor 4F (18, 19, 29). The integrity of p220 seems to be required 
for the translation of cellular mRNAs but not for the initiation 
of translation at vRNA, which occurs by internal entry of 
ribosomes to internal ribosome entry site elements in the 5 ' 
nontranslated region (25, 38). However, several reports have 
described that substantial levels (25 to 45%) of cellular protein 
synthesis can take place in cells in which all p220 has been 
degraded (10, 24, 39). It has therefore been suggested that the 
p220 cleavage is necessary but not sufficient to completely 
inhibit host cell protein synthesis and that a second event, 
which requires RNA replication, is required to block cellular 
translation. The permeabilization of the plasma membrane 
and the resulting influx of sodium ions have been suggested as 
potential second events. High concentrations of sodium ions 
are inhibitory to host mRNA translation but not to the trans­
lation of vRNAs (12). The reversal of the shutoff and the 
continuous synthesis of cellular proteins that occur in sodium- 
free medium are further indicative for a role of sodium ions in 
the inhibition of cellular protein synthesis (13).
Recently, it has been shown that of the PV nonstructural 
proteins, protein 2B has the highest intrisic capacity to modify 
the plasma membrane permeability to hygromycin B in human 
cells (16). This capacity was found to be conserved in CBV3 
protein 2B (49), which contains a cationic amphipathic a-he- 
lical motif that is required for vRNA replication and that is 
typical for so-called lytic polypeptides (47). In this study, we 
have shown that the failure of mutant coxsackieviruses con- 
taining poorly processed 2B/2C cleavage sites to completely 
shut off host cell translation coincided with a reduction of 
levels of mature proteins 2B and 2C, but not of protein 2Apr,\  
and a reduced ability to modify the plasma membrane perme­
ability. These data suggest that the permeabilization of the 
plasma membrane by protein 2B may indeed be the second 
event required for the shutoff of cellular translation. Reduced 
levels of protein 2B may be responsible for a poor permeabi­
lization of the plasma membrane and, as a consequence, a 
reduced influx of sodium ions. The failure to increase the 
intracellular sodium concentration could account for the main­
tenance of host cell translation, the reduction in viral protein 
synthesis, and the reduced virus yield. However, it should be 
emphasized that normal levels of protein 2A were demon­
strated in vitro but not yet in vivo. Furthermore, as it remains 
to be established that an increased membrane permeability 
contributes to the inhibition of cellular translation, it cannot be 
excluded that the accumulation of either protein 2B or 2C, or 
both, is required for another, yet unidentified process that is 
necessaiy to fully suppress cellular protein synthesis. In addi­
tion, the mutations introduced near the 2B/2C cleavage site 
may affect not only the relative amounts of 2BC, 2B, and 2C 
but also their functions. Additional studies on the functions of 
the P2 region proteins are required to shed more light on the 
possible participation of these proteins in the shutoff of host 
cell protein synthesis.
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